Sona Nanotech Inc

Explore Sona Nanotech’s breakthrough 80% response in first‑in‑human cancer trial and its mining strategy across Kenya, Canada, Mexico, and its market outlook.

Explore Sona Nanotech’s journey from mining to breakthrough cancer trials, uncovering its high‑risk, high‑reward prospects in the materials sector.

Discover how Sona Nanotech Inc., a Canadian metals and mining firm, is driving cancer therapy breakthroughs with an 80% response rate while navigating volatile stock prices and high growth potential.

Explore Sona Nanotech’s struggle in metals & mining: negative P/E, sharp stock decline, and a reverse‑merger acquisition that hasn’t yet paid off.

Sona Nanotech Inc. has made significant strides in the metals and mining industry through strategic acquisitions and exploration activities in Kenya, Canada, and Mexico, positioning it as a key player in the sector.

Sona Nanotech Inc. is a Canadian company pioneering innovation in the metals and mining industry, with a focus on sustainable practices and exploration of mineral properties.

Sona Nanotech Inc. is a Canadian company that is making a name for itself in the metals and mining industry through its innovative approach and strategic acquisitions, positioning it for growth and stability.

Sona Nanotech Inc. has announced a first-in-human clinical trial for its Targeted Hyperthermia Therapy (THT) in patients with advanced melanoma, marking a significant step in the company’s pivot into oncology and life sciences.